The Opioid Induced Constipation (OIC) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Opioid Induced Constipation (OIC) Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Opioid Induced Constipation (OIC) Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Opioid Induced Constipation (OIC) Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Other
Market segment by Application can be divided into
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The key market players for global Opioid Induced Constipation (OIC) Drug market are listed below:
- Ironwood Pharmaceuticals
- Daiichi Sankyo Co
- Pfizer
- Progenics Pharmaceuticals
- Shionogi &
- Allergan
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma
- Mundipharma International Limited
- Ono Pharmaceutical
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
Market segment by Region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Opioid Induced Constipation (OIC) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Induced Constipation (OIC) Drug, with price, sales, revenue and global market share of Opioid Induced Constipation (OIC) Drug from 2019 to 2021.
Chapter 3, the Opioid Induced Constipation (OIC) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation (OIC) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Opioid Induced Constipation (OIC) Drug market forecast, by regions, type and distribution channel, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Opioid Induced Constipation (OIC) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Global Opioid Induced Constipation (OIC) Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
Table of Contents
1 Market Overview
1.1 Opioid Induced Constipation (OIC) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioid Induced Constipation (OIC) Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Market Analysis by Distribution Channel
1.3.1 Overview: Global Opioid Induced Constipation (OIC) Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation (OIC) Drug Market Size & Forecast
1.4.1 Global Opioid Induced Constipation (OIC) Drug Sales in Value (2016-2026))
1.4.2 Global Opioid Induced Constipation (OIC) Drug Sales in Volume (2016-2026)
1.4.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Opioid Induced Constipation (OIC) Drug Production Capacity Analysis
1.5.1 Global Opioid Induced Constipation (OIC) Drug Total Production Capacity (2016-2026)
1.5.2 Global Opioid Induced Constipation (OIC) Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioid Induced Constipation (OIC) Drug Market Drivers
1.6.2 Opioid Induced Constipation (OIC) Drug Market Restraints
1.6.3 Opioid Induced Constipation (OIC) Drug Trends Analysis
2 Manufacturers Profiles
2.1 Ironwood Pharmaceuticals
2.1.1 Ironwood Pharmaceuticals Details
2.1.2 Ironwood Pharmaceuticals Major Business
2.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Daiichi Sankyo Co
2.2.1 Daiichi Sankyo Co Details
2.2.2 Daiichi Sankyo Co Major Business
2.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product and Services
2.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Product and Services
2.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Progenics Pharmaceuticals
2.4.1 Progenics Pharmaceuticals Details
2.4.2 Progenics Pharmaceuticals Major Business
2.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Shionogi &
2.5.1 Shionogi & Details
2.5.2 Shionogi & Major Business
2.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Product and Services
2.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Opioid Induced Constipation (OIC) Drug Product and Services
2.6.4 Allergan Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Nektar Therapeutics
2.7.1 Nektar Therapeutics Details
2.7.2 Nektar Therapeutics Major Business
2.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product and Services
2.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Purdue Pharma
2.8.1 Purdue Pharma Details
2.8.2 Purdue Pharma Major Business
2.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product and Services
2.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 S.L.A. Pharma
2.9.1 S.L.A. Pharma Details
2.9.2 S.L.A. Pharma Major Business
2.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product and Services
2.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Mundipharma International Limited
2.10.1 Mundipharma International Limited Details
2.10.2 Mundipharma International Limited Major Business
2.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product and Services
2.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Ono Pharmaceutical
2.11.1 Ono Pharmaceutical Details
2.11.2 Ono Pharmaceutical Major Business
2.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
2.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Theravance Biopharma
2.13.1 Theravance Biopharma Details
2.13.2 Theravance Biopharma Major Business
2.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product and Services
2.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Bausch Health
2.14.1 Bausch Health Details
2.14.2 Bausch Health Major Business
2.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Product and Services
2.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Cosmo Pharmaceuticals SA
2.15.1 Cosmo Pharmaceuticals SA Details
2.15.2 Cosmo Pharmaceuticals SA Major Business
2.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product and Services
2.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Daewoong Pharmaceutical
2.16.1 Daewoong Pharmaceutical Details
2.16.2 Daewoong Pharmaceutical Major Business
2.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
2.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business
2.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product and Services
2.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Sucampo Pharmaceuticals
2.18.1 Sucampo Pharmaceuticals Details
2.18.2 Sucampo Pharmaceuticals Major Business
2.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
2.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Opioid Induced Constipation (OIC) Drug Sales by Manufacturer
3.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Opioid Induced Constipation (OIC) Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share
3.4.2 Top 6 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share
3.5 Global Opioid Induced Constipation (OIC) Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Opioid Induced Constipation (OIC) Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2016-2026)
4.2 North America Opioid Induced Constipation (OIC) Drug Revenue (2016-2026)
4.3 Europe Opioid Induced Constipation (OIC) Drug Revenue (2016-2026)
4.4 Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue (2016-2026)
4.5 South America Opioid Induced Constipation (OIC) Drug Revenue (2016-2026)
4.6 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Type (2016-2026)
5.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2016-2026)
5.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Opioid Induced Constipation (OIC) Drug Sales in Volume by Application (2016-2026)
6.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2016-2026)
6.3 Global Opioid Induced Constipation (OIC) Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2026)
7.2 North America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2026)
7.3 North America Opioid Induced Constipation (OIC) Drug Market Size by Country
7.3.1 North America Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2026)
8.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2026)
8.3 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country
8.3.1 Europe Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region
9.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2026)
10.2 South America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2026)
10.3 South America Opioid Induced Constipation (OIC) Drug Market Size by Country
10.3.1 South America Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Market Size by Country
11.3.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Opioid Induced Constipation (OIC) Drug Typical Distributors
12.3 Opioid Induced Constipation (OIC) Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Opioid Induced Constipation (OIC) Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Opioid Induced Constipation (OIC) Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Ironwood Pharmaceuticals Major Business
Table 5. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 6. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Daiichi Sankyo Co Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Co Major Business
Table 9. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product and Services
Table 10. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Opioid Induced Constipation (OIC) Drug Product and Services
Table 14. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Progenics Pharmaceuticals Major Business
Table 17. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 18. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Shionogi & Basic Information, Manufacturing Base and Competitors
Table 20. Shionogi & Major Business
Table 21. Shionogi & Opioid Induced Constipation (OIC) Drug Product and Services
Table 22. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Allergan Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Major Business
Table 25. Allergan Opioid Induced Constipation (OIC) Drug Product and Services
Table 26. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Nektar Therapeutics Major Business
Table 29. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product and Services
Table 30. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Purdue Pharma Major Business
Table 33. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 34. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. S.L.A. Pharma Basic Information, Manufacturing Base and Competitors
Table 36. S.L.A. Pharma Major Business
Table 37. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 38. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mundipharma International Limited Basic Information, Manufacturing Base and Competitors
Table 40. Mundipharma International Limited Major Business
Table 41. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product and Services
Table 42. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Ono Pharmaceutical Major Business
Table 45. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
Table 46. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Company Limited Major Business
Table 49. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product and Services
Table 50. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 52. Theravance Biopharma Major Business
Table 53. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product and Services
Table 54. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 56. Bausch Health Major Business
Table 57. Bausch Health Opioid Induced Constipation (OIC) Drug Product and Services
Table 58. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Cosmo Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 60. Cosmo Pharmaceuticals SA Major Business
Table 61. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product and Services
Table 62. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Daewoong Pharmaceutical Major Business
Table 65. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product and Services
Table 66. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. C.B. Fleet Company Basic Information, Manufacturing Base and Competitors
Table 68. C.B. Fleet Company Major Business
Table 69. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product and Services
Table 70. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Sucampo Pharmaceuticals Major Business
Table 73. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product and Services
Table 74. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 76. Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Opioid Induced Constipation (OIC) Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Opioid Induced Constipation (OIC) Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Opioid Induced Constipation (OIC) Drug Production Site of Key Manufacturer
Table 80. Opioid Induced Constipation (OIC) Drug New Entrant and Capacity Expansion Plans
Table 81. Opioid Induced Constipation (OIC) Drug Mergers & Acquisitions in the Past Five Years
Table 82. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2016-2021e) & (K Units)
Table 83. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2021-2026) & (K Units)
Table 84. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2021e) & (K Units)
Table 87. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units)
Table 88. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Opioid Induced Constipation (OIC) Drug Price by Type (2016-2021e) & (USD/Unit)
Table 91. Global Opioid Induced Constipation (OIC) Drug Price by Type (2021-2026) & (USD/Unit)
Table 92. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2021e) & (K Units)
Table 93. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units)
Table 94. Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Opioid Induced Constipation (OIC) Drug Price by Application (2016-2021e) & (USD/Unit)
Table 97. Global Opioid Induced Constipation (OIC) Drug Price by Application (2021-2026) & (USD/Unit)
Table 98. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2016-2021e) & (K Units)
Table 99. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units)
Table 100. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2021e) & (K Units)
Table 103. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units)
Table 104. North America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2021e) & (K Units)
Table 105. North America Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units)
Table 106. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2016-2021e) & (K Units)
Table 107. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units)
Table 108. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2021e) & (K Units)
Table 111. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units)
Table 112. Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2021e) & (K Units)
Table 113. Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units)
Table 114. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2016-2021e) & (K Units)
Table 115. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2021-2026) & (K Units)
Table 116. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2021e) & (K Units)
Table 119. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units)
Table 120. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2021e) & (K Units)
Table 121. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units)
Table 122. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2016-2021e) & (K Units)
Table 123. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units)
Table 124. South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Opioid Induced Constipation (OIC) Drug Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2021e) & (K Units)
Table 127. South America Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units)
Table 128. South America Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2021e) & (K Units)
Table 129. South America Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units)
Table 130. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2016-2021e) & (K Units)
Table 131. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2021-2026) & (K Units)
Table 132. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2016-2021e) & (K Units)
Table 135. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2021-2026) & (K Units)
Table 136. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2016-2021e) & (K Units)
Table 137. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2021-2026) & (K Units)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Opioid Induced Constipation (OIC) Drug Typical Distributors
Table 141. Opioid Induced Constipation (OIC) Drug Typical Customers
List of Figures
Figure 1. Opioid Induced Constipation (OIC) Drug Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2020
Figure 3. Lubiprostone
Figure 4. Methyl Naltrexone Bromide
Figure 5. Naldemedine
Figure 6. Alvimopan
Figure 7. Other
Figure 8. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Opioid Induced Constipation (OIC) Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Opioid Induced Constipation (OIC) Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales (2016-2026) & (K Units)
Figure 15. Global Opioid Induced Constipation (OIC) Drug Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Opioid Induced Constipation (OIC) Drug Production Capacity (2016-2026) & (K Units)
Figure 17. Global Opioid Induced Constipation (OIC) Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Opioid Induced Constipation (OIC) Drug Market Drivers
Figure 19. Opioid Induced Constipation (OIC) Drug Market Restraints
Figure 20. Opioid Induced Constipation (OIC) Drug Market Trends
Figure 21. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Opioid Induced Constipation (OIC) Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Opioid Induced Constipation (OIC) Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Opioid Induced Constipation (OIC) Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Opioid Induced Constipation (OIC) Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Opioid Induced Constipation (OIC) Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Opioid Induced Constipation (OIC) Drug Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Opioid Induced Constipation (OIC) Drug Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2016-2026)
Figure 41.
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
